Feedback / Questions
Ac-225 rosopatamab tetraxetan (CONV01-α) - Dominari Holdings
https://www.prnewswire.com/news-releases/convergent-therapeutics-announces-two-clinical-trial-updates-on-conv01--at-the-american-society-of-clinical-oncology-asco-genitourinary-cancers-symposium-2025-302372722.html
Feb 10, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next